Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-02

FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for metformin hydrochloride submitted by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

SUPPL AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)